380 filings
Page 6 of 19
8-K
e2a25h
13 May 21
PAVmed Subsidiary Lucid Diagnostics Announces Upcoming Presentation at Digestive Disease Week 2021
4:30pm
8-K
tpy3l ia0c
6 May 21
Four new senior executives will support growth strategy focused on multi-channel EsoGuard commercialization
4:30pm
8-K
xkyl364nw5yhw f72
29 Apr 21
Dr. Jacque Sokolov Joins PAVmed Subsidiary Lucid Diagnostics’ Board of Directors
4:30pm
8-K
lin5xm0p64rj69w5
27 Apr 21
Departure of Directors or Certain Officers
4:15pm
8-K
c2ev3n j1u
19 Apr 21
Regulation FD Disclosure
4:30pm
8-K
i1ua9dlhhj3zhpt3fk6
12 Apr 21
Other Events
4:39pm
8-K
h9laftr a7lh2loalcvh
5 Mar 21
Departure of Directors or Certain Officers
5:00pm
8-K
qjbzmt y6n
3 Mar 21
Termination of a Material Definitive Agreement
9:30am
8-K
kgtk6n87x5x 8l
25 Feb 21
PAVmed Announces Closing of its Public Offering of Common Stock
4:30pm
8-K
x99xfb52x 9ai0vf42
24 Feb 21
PAVmed Announces Proposed Public Offering of Common Stock
5:27pm
424B5
qnj92tynmmfg0y
24 Feb 21
Prospectus supplement for primary offering
5:26pm
S-3MEF
3yb1mv vv84f
23 Feb 21
Registration of additional securities for an S-3
8:51am
424B5
iocm 49jgyg118u1zl
22 Feb 21
Prospectus supplement for primary offering
5:31pm
8-K
epb485yn
22 Feb 21
PAVmed Provides Business Update and Preliminary Fourth Quarter 2020 Financial Results
8:41am
8-K
7i3pkdnicpu
16 Feb 21
Regulation FD Disclosure
9:30am
8-K
wy7xk wq9
15 Jan 21
Amendments to Articles of Incorporation or Bylaws
4:31pm